language Country


The Complete Guide to Successful Teleretinal Programs [eBook]


Diabetic retinopathy is the leading cause of blindness among working-age adults.1 This is a serious issue as the number of people living with diabetes increases, so does the number of people with impaired vision.2 There are approximately 463 million people in the world living with diabetes3 and up to 80% of individuals with diabetes will develop some level of diabetic retinopathy.4 Between 40-45% of Americans diagnosed with diabetes have some stage of diabetic retinopathy, although only about half are aware of it.1 But the solution is in sight – diabetic retinopathy is up to 95% preventable with early detection and treatment.1 

Check out the interactive eBook, The Solution is in Sight: The Complete Guide to Successful Teleretinal Programs, to learn more about what teleretinal imaging can do for your patients and primary care practice.

What’s inside the eBook:

  • An overview of diabetic retinopathy and the current standard of care 
  • How to select the right retinal camera for your workflow 
  • The three keys to a successful teleretinal program 
  • CPT® Code coverage for fundus imaging and teleretinal programs 
  • Improve HEDIS®, STAR and HCC risk factors by closing care gaps
cover of the eBook titled The Complete Guide to Successful Teleretinal Programs


  1. National Eye Institute. Facts about Diabetic Eye Disease. https://www.​nei.​nih.​gov/learn-about-eye-health/eye-conditions-and-diseases/ diabeticretinopathy. Accessed November 17, 2020.
  2. CDC Vision Health Initiative (VHI), Common Eye Disorders. www.​cdc.​gov/visionhealth/basics/ced/index.​html.​ Accessed November 17, 2020.
  3. Williams R, Colagiuri S, Almutairi, R, et al. IDF diabetes atlas. 9th ed. Brussels, Belgium: International Diabetes Federation; 2019.
  4. Duration of diabetes is a major risk factor associated with the development of diabetic retinopathy. After five years, approximately 25% of type 1 patients will have retinopathy, increasing to 80% after 15 years. For type 2 patients, the risk of developing retinopathy is 84% and 53% after 19 years for those taking or not taking insulin, respectively. Diabetic Retinopathy Preferred Practice Pattern® from the American Academy of Ophthalmology, http://dx.​doi.​org/10.1016/j.ophtha.2019.09.025, ISSN 0161-6420/19. Accessed July 29, 2020.